Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,285 | 15,391 | 17,517 | 10,738 | 12,234 |
| Receivables | 179 | 196 | 326 | 442 | 810 |
| TOTAL | $11,464 | $15,587 | $17,843 | $11,180 | $13,044 |
| Non-Current Assets | |||||
| PPE Net | 11,214 | 12,514 | 12,386 | 11,956 | 11,957 |
| Other Non-Current Assets | 1,771 | 1,980 | 1,807 | 1,957 | 2,008 |
| TOTAL | $12,985 | $14,494 | $14,193 | $13,913 | $13,965 |
| Total Assets | $24,449 | $30,081 | $32,036 | $25,093 | $27,009 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,345 | N/A | N/A | 19,972 | 19,708 |
| Accounts payable and accrued liabilities | 1,130 | 2,425 | 2,069 | 1,550 | 1,342 |
| TOTAL | $6,720 | $2,677 | $2,444 | $21,763 | $21,284 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,843 | 20,524 | 27,164 | N/A | N/A |
| Other Non-Current Liabilities | 1,609 | 1,789 | 1,446 | 2,034 | 2,232 |
| TOTAL | $16,452 | $22,313 | $28,610 | $2,034 | $2,232 |
| Total Liabilities | $23,172 | $24,990 | $31,054 | $23,797 | $23,516 |
| Shareholders' Equity | |||||
| Retained earnings | -110,582 | -117,817 | -110,039 | -109,637 | -105,820 |
| Other shareholders' equity | 0 | 0 | -2,055 | 0 | 0 |
| TOTAL | $1,277 | $5,091 | $982 | $1,296 | $3,493 |
| Total Liabilities And Equity | $24,449 | $30,081 | $32,036 | $25,093 | $27,009 |